The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Clinical trial NCT05723640 · COMPLETED

Trial details

NCT number: NCT05723640
Sponsor: Yantai LNC Biotechnology Singapore PTE. LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Unspecified, Adult

Start date: 2023-10-03
Primary completion: 2024-09-25
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.